C07C 217/54
Compounds containing amino and etherified hydroxy groups bound to the same carbon
Official title: having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
C07C217/54 (Compounds containing amino and etherified hydroxy groups bound to the same carbon) appears on 1,055 US grants and 974 published applications in this corpus.
Search patents in C07C- Granted patents
- 1,055
- Published applications
- 974
- Assignees
- 579
- Inventors
- 3,009
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 6 | 0 |
| 1978 | 3 | 0 |
| 1979 | 4 | 0 |
| 1980 | 6 | 0 |
| 1981 | 2 | 0 |
| 1982 | 4 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 7 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 9 | 0 |
| 1989 | 9 | 0 |
| 1990 | 10 | 0 |
| 1991 | 19 | 0 |
| 1992 | 24 | 0 |
| 1993 | 32 | 0 |
| 1994 | 20 | 0 |
| 1995 | 31 | 0 |
| 1996 | 23 | 0 |
| 1997 | 32 | 0 |
| 1998 | 28 | 0 |
| 1999 | 23 | 0 |
| 2000 | 24 | 0 |
| 2001 | 31 | 5 |
| 2002 | 40 | 42 |
| 2003 | 24 | 63 |
| 2004 | 43 | 51 |
| 2005 | 26 | 34 |
| 2006 | 20 | 41 |
| 2007 | 26 | 32 |
| 2008 | 23 | 31 |
| 2009 | 18 | 44 |
| 2010 | 25 | 41 |
| 2011 | 21 | 32 |
| 2012 | 32 | 46 |
| 2013 | 36 | 53 |
| 2014 | 38 | 50 |
| 2015 | 47 | 57 |
| 2016 | 48 | 54 |
| 2017 | 33 | 37 |
| 2018 | 34 | 40 |
| 2019 | 29 | 23 |
| 2020 | 28 | 31 |
| 2021 | 17 | 39 |
| 2022 | 26 | 23 |
| 2023 | 13 | 28 |
| 2024 | 20 | 32 |
| 2025 | 13 | 27 |
| 2026 | 13 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Substituted diaryl compound as well as preparation method and application thereof29 Sep 2026US 12,747,209 B2Shandong First Medical. Univ & Shandong Academy of Medical Sciences
- Compound, cellular vesicle staining agent, and method of fluorescent staining for cellular vesicles11 Aug 2026US 12,704,443 B2National University Corporation Tokai National Higher Education and Research System
- 5-methoxymethyl and 5-hydroxymethyl phenethylamines28 Jul 2026US 12,692,221 B22A Biosciences, Inc.
- Compound for treating Alzheimer's disease16 Jun 2026US 12,655,088 B2East China University of Science and Technology
- Indane-, indene-, azaindane-, and azaindene-amines as activators of serotonin receptors26 May 2026US 12,636,266 B2Rivo Bio, Inc.
- Compositions and methods for the treatment of ocular disorders8 Oct 2026US 2026/0308108 A1
- Conformationally restricted phenethylamine analogs8 Oct 2026US 2026/0308109 A1
- Selective Serotonin Receptor Modulators and Methods of Making and Using the Same8 Oct 2026US 2026/0308110 A1Park City Bio, LLC
- Treatment and diagnosis of melanoma17 Sep 2026US 2026/0272867 A1The Rockefeller University
- Selective Serotonin Receptor Modulators and Methods of Making and Using the Same10 Sep 2026US 2026/0265173 A1Park City Bio, LLC
Most cited
By later US patents
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Aryloxypropanolamine .beta. 3 adrenergic agonists115US 5,541,204 ABristol-Myers Squibb Company · 1996
- Calcium receptor-active compounds114US 6,211,244 B1NPS Pharmaceuticals, Inc. · 2001
- Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist104US 5,460,605 AGensia, Inc. · 1995
- 1-phenyl-2-dimenthylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients95US 5,801,201 AGruenenthal GmbH · 1998